Clearpoint Neuro Inc (CLPT) Growth Rates Comparisons to Medical Equipment & Supplies Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Suppliers, else..
 
Clearpoint Neuro Inc   (NASDAQ: CLPT)
 

Clearpoint Neuro Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CLPT Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 18.07 % 6.57 % 8.91 % 10.9 %
Q / Q Revenue Growth (Q2 MRQ) -10.29 % -1.87 % -3.28 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 25.86 % 7.21 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) 4.1 % 1.5 % 2.03 % 2.61 %
Revenue 5 Year Average Growth 23.58 % 10.68 % 8.65 % 10.59 %


CLPT's Growth Comparisons in II. Quarter 2026




Clearpoint Neuro Inc 's 18.07% year on year Revenue growth, has slowed-down in the second quarter 2026 to 11 millions, but outperforms the 6.57% growth in the Medical Equipment & Supplies industry, and 8.91% growth in the Healthcare sector. Despite modest Sales rises in the Healthcare sector and in the Medical Equipment & Supplies industry, Clearpoint Neuro Inc reported above average market Sales growth.

Sequentially company's Revenue fell by -10.29% from the first quarter results. . Looking into annual growth, sales grew by 23.58% on average in last five years, while S & P 500's including only Businesses with the second quarter 2026 earnings reports, average yearly sales growth is 10.59%.

CLPT Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Product
-
-
Service
-
-
Biologics and Drug Delivery - Services and license fees
-
-
Neurosurgery Navigation and Therapy - Disposable Products
74.85 %
1.94 %
Biologics and drug delivery
86.52 %
83.84 %
Neurosurgery Navigation and Therapy Disposable Products
-
-
Neurosurgery navigation and therapy
233.3 %
94.31 %
Capital Equipment and Software-Related Service
0.05 %
-17.35 %
Capital Equipment and Software - Systems and Software Products
58.5 %
7.84 %
Total
18.07 %
-10.29 %


Growth Rates of CLPT's Income in the second quarter 2026


CLPT Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) - 11.6 % 4.62 % 97.6 %
Sequential Operating Income Change (Q2 MRQ) - 96.14 % 0.89 % 48.13 %
Y / Y Operating Income Growth (Q2 TTM) - 13.68 % 30.73 % 40.67 %
Sequential Operating Income Growth (Q2 TTM) - 2.92 % 4.82 % 20.86 %
Operating Income 5 Year Avg. Change - 11.5 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) - -10.42 % -25.98 % 90.69 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) - 19.69 % -66.16 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) - 16.79 % 2.68 % 57.33 %
Sequential Income from Cont. Ops. Change (Q2 TTM) - -2.7 % -5.02 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - 5.35 % 0.17 % -28.52 %

CLPT Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) - -12.37 % -26.26 % 90.69 %
Q / Q Net Income Growth (Q2 MRQ) - 44.98 % -0.77 % 27.07 %
Y / Y Net Income Change (Q2 TTM) - -0.27 % 15.51 % 57.33 %
Sequential Net Income Change (Q2 TTM) - -3.32 % -6.72 % 18.65 %
Net Income 5 Year Avg. Growth - 4.12 % 9.21 % 22.96 %

CLPT's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) - -16.23 % -25.98 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) - 15.71 % -66.16 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) - - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth - -1.8 % 0.17 % -28.52 %



CLPT EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) - -18.05 % -26.26 % -28.52 %
Q / Q EPS Net Growth (Q2 MRQ) - 40.16 % -0.77 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) - - - 4.93 %
EPS Net 5 Year Avg. Change - 4.12 % 9.21 % 22.96 %



Clearpoint Neuro Inc reported bottom-line of $ -0.38 in the second quarter, compare to $ -0.21 in the same quarter a year ago. Medical Equipment & Supplies industry fell by -18.05%, while Healthcare sector decreased by -26.26%, and overall market improved by 90.69%.

Sequentially company's EPS fell by -10.29% from the first quarter results. . Looking into annual growth, income per share grew by 23.58% on average in last five years, while S & P 500's including only Businesses with the second quarter 2026 reports, average yearly income per share growth is 22.96%.

CLPT Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) - 63.77 % 48.49 % 48.62 %
Sequential Free Cash Flow Change (Q2 MRQ) - -54.09 % -46.96 % 34.18 %
Y / Y Free Cash Flow Change (Q2 TTM) - 39.68 % 18.61 % 60.27 %
Sequential Free Cash Flow Change (Q2 TTM) - 8.02 % 5.39 % 15.75 %
Free Cash Flow 5 Year Avg. Change - 3.81 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q2 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q2 TTM) - - - 209.43 %
Sequential Net Cash Flow Change (Q2 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change 13.28 % -9.69 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) 135.16 % 4.81 % 8.23 % 120.03 %
Sequential Capital Expenditures Change (Q2 MRQ) -66.82 % -21.5 % -22.09 % 36.87 %
Y / Y Capital Expenditures Change (Q2 TTM) 101.64 % -1.63 % 7.87 % 109.38 %
Sequential Capital Expenditures Change (Q2 TTM) 12.5 % -1.55 % 1.6 % 23.05 %
Capital Expenditures 5 Year Avg. Change 66.33 % 8.3 % 9.18 % 14.72 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.